MD Anderson Cancer Center Offers an Essential 6-Day Course: Mastering Hematology & Oncology for ABIM Success
MD Anderson Cancer Center shared an inviting post on X:
”A virtual live-streaming course will offer comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.”
To learn more and register, follow the link.
A 6-day virtual course by MD Anderson Cancer Center and Baylor College of Medicine offers a comprehensive review of current practices in managing blood disorders and malignancies, tailored to help participants prepare for the ABIM certification in Hematology and Medical Oncology.
The program covers key updates in pharmacology, molecular genetics, risk assessment, and radiation oncology.
By the end of the course, participants will be equipped to:
- Confidently prepare for hematology and medical oncology subspecialty and recertification exams.
- Apply up-to-date standards of care in treating cancer, blood disorders, and malignancies.
- Demonstrate comprehensive knowledge in hematology and medical oncology.
- Integrate recent advances into the management of hematologic and oncologic patients.
Don’t miss your chance, apply now!
Stay informed on the latest conferences, courses, and webinars—read Hemostasis Today for all the updates!
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’